INS and metabolic dysfunction-associated steatotic liver disease: Compared to the central adiposity characterized in NAFLD, those with PWS are known to have relative increased subcutaneous adiposity but lower visceral adiposity and lean body mass [23,25,26,27,47,48,49] and better metabolic profiles with increased insulin sensitivity [27].